| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/01/2009 | WO2009118375A2 Stabilized liquid enzyme compositions |
| 10/01/2009 | WO2009067225A4 Boceprevir derivatives for the treatment of hcv infections |
| 10/01/2009 | US20090247731 Boronic ester and acid compounds, synthesis and uses |
| 10/01/2009 | US20090247608 Targeting Lipids |
| 10/01/2009 | US20090247468 Spray drying a drug such as telaprevir; VX 770 is excluded; including a non-volatile or high boiling solvent during spray drying of a drug can improve the properties of resulting product |
| 10/01/2009 | US20090246340 Synthetic Ligands Able to Bind Ochratoxin A and Uses Thereof |
| 10/01/2009 | US20090246217 Novel Peptides for Treating and Preventing Immune-Related Disorders, Including Treating and Preventing Infection by Modulating Innate Immunity |
| 10/01/2009 | US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 10/01/2009 | CA2715816A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
| 09/30/2009 | EP2104535A1 Compounds and compositions as channel activating protease inhibitors |
| 09/30/2009 | CN101544687A Kyrine analog, preparing method thereof, medical composition containing the kyrine analog and application thereof |
| 09/30/2009 | CN100545160C Diamine derivatives |
| 09/29/2009 | US7595299 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/29/2009 | US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity |
| 09/29/2009 | US7595173 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | CA2458474C Zwitterionic lipid compound and uses thereof |
| 09/24/2009 | WO2009117539A2 Bioluminescent construct |
| 09/24/2009 | WO2009115658A2 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 09/24/2009 | WO2009115288A1 Thiostrepton probe |
| 09/24/2009 | WO2009115287A1 Thiostrepton derivatives |
| 09/24/2009 | WO2009081152A3 Antimicrobial compounds |
| 09/24/2009 | WO2008057608A3 Synthetic peptide amides |
| 09/24/2009 | US20090240027 Intermediates for macrocyclic compounds |
| 09/24/2009 | US20090239809 Process For Preparing Peptide Products For Promoting Cholecystokinin Secretion And Use Of The Peptide Products |
| 09/24/2009 | US20090239808 Calcium receptor activator |
| 09/24/2009 | US20090239755 Identification of Compounds Modifying A Cellular Response |
| 09/24/2009 | US20090239310 Kokumi-imparting agent |
| 09/24/2009 | US20090238794 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | US20090238766 Bioluminescent construct |
| 09/24/2009 | CA2715272A1 A high throughput protein interaction assay |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103623A2 Novel macrocyclic inhibitors of Hepatitis C virus replication |
| 09/23/2009 | EP2102230A2 Purifiction of romidepsin |
| 09/23/2009 | EP2102229A1 Pyrrolydine derivatives as iap inhibitors |
| 09/23/2009 | EP1581557B1 Metastin derivatives and their use |
| 09/23/2009 | EP1558632B1 Macrocyclic peptides active against the hepatitis c virus |
| 09/23/2009 | EP1501935B1 Low-cost production of peptides |
| 09/23/2009 | CN101541827A Crystal of glutathione and process for production thereof |
| 09/23/2009 | CN101541826A Macrocyclic HCV inhibitors and their uses |
| 09/23/2009 | CN101538312A Preparation and applications of RGD-fatty amine series compound as tumor targeting vector material |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN100543032C Streptogramin derivatives, preparation and compositions containing them |
| 09/23/2009 | CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592316 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/22/2009 | US7592304 Metal-binding compounds and uses therefor |
| 09/17/2009 | WO2009112645A1 Peptide for activating aquaporin synthesis |
| 09/17/2009 | WO2009019531A3 Bioactive peptides and method of using same |
| 09/17/2009 | US20090234098 Method of preparing peptide |
| 09/17/2009 | US20090234097 Vasodilator |
| 09/17/2009 | US20090234095 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 09/17/2009 | US20090233872 Therapeutic Agent for Neurodegenerative Disease |
| 09/17/2009 | US20090233366 Composition for introduction of nucleic acid |
| 09/17/2009 | US20090232821 Use Of A Growth-Stimulating Protein |
| 09/16/2009 | EP2100899A2 Compounds for proteasome enzyme inhibition |
| 09/16/2009 | EP2099815A2 Novel amides acting on the adenosine receptors |
| 09/16/2009 | EP2099467A2 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 09/16/2009 | EP1951276B1 Oligopeptides and their use |
| 09/16/2009 | EP1924593B1 Hcv ns3 protease inhibitors |
| 09/16/2009 | EP1661909B1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/16/2009 | CN101535336A Synthetic peptide amides and dimers thereof |
| 09/16/2009 | CN101531702A Super-sweet dipeptide compound containing halogen and preparation method and application thereof |
| 09/16/2009 | CN100540526C Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/15/2009 | US7589170 Synthesis of cyclic peptides |
| 09/15/2009 | US7589066 Such as N-carbobenzyloxy-phenylalanyl-phenylalanylal; for treating cancer, inflammation, and/or autoimmune diseases; suppresses endogenous antigenic peptide generation |
| 09/15/2009 | US7589065 Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2149925C Peptidic derivates of .alpha.-msh and their uses |
| 09/11/2009 | CA2710964A1 Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices |
| 09/10/2009 | US20090227520 Treatment methods using peptides related to amyloid precursor protein |
| 09/10/2009 | US20090227505 Methods and uses for protein breakdown products |
| 09/10/2009 | US20090227491 Antiviral phosphinate compounds |
| 09/10/2009 | US20090226374 Anaphylatoxins for detecting clinical conditions |
| 09/09/2009 | EP2097093A2 Therapeutic and diagnostic peptides |
| 09/09/2009 | EP2097090A2 Peptide and treatment for hiv-1 infection |
| 09/09/2009 | EP1709179B1 Transgenic plants with reduced level of saturated fatty acid and methods for making them |
| 09/09/2009 | CN101528765A Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders |
| 09/09/2009 | CN101525300A Apply to ink compounds and compounds with such ink |
| 09/09/2009 | CN100537599C Anti-thrombocyte tetratitanate-NB06 and its application |
| 09/09/2009 | CN100537598C Substantially crystalline form of melagatran |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585943 Peptide linker comprising thrombin cleavage site; enhancing recovery and purification of exogenously expressed polypeptides |
| 09/08/2009 | US7585939 Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes |
| 09/08/2009 | US7585938 Gamma-secretase inhibitors |
| 09/08/2009 | US7585849 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 09/08/2009 | US7585846 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 09/08/2009 | US7585845 Using protease inhibitor |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2290481C Peptide-coated implants and processes for their preparation |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2281955C Ikb kinase, subunits thereof, and methods of using same |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/03/2009 | WO2009106715A2 Peptide derived from a protein of the aquaporin family and cosmetic and/or pharmaceutical composition containing same |
| 09/03/2009 | WO2009106343A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | WO2009055054A3 Antibody-mediated disruption of quorum sensing in bacteria |
| 09/03/2009 | WO2008095033A8 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |